Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (251-260 of 635) with videos related to

Pageof 64
Sort By:
Journal of the American College of Cardiology|December 17, 2016
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II RegistryBenjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
Journal of the American College of Cardiology|February 11, 2003
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patientsPadma Kaul, L Kristin Newby, Yuling Fu, et al.
Circulation|December 14, 2021
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADERAhmed M Shaman, Stephen C Bain, George L Bakris, et al.
Circulation. Cardiovascular Quality and Outcomes|September 20, 2012
Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trialSteen Husted, Stefan James, Richard C Becker, et al.
American Heart Journal|July 5, 2024
Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health studyJacquelyn B Kercheval, Dennis I Narcisse, Maggie Nguyen, et al.
The American Journal of Cardiology|February 22, 2005
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)Manesh R Patel, Kenneth W Mahaffey, Paul W Armstrong, et al.
Stroke|April 29, 2006
Statin use and sex-specific stroke outcomes in patients with vascular diseaseCheryl D Bushnell, Jeffrey Griffin, L Kristin Newby, et al.
Journal of the American College of Cardiology|September 9, 2017
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF RegistryJustin B Echouffo-Tcheugui, Peter Shrader, Laine Thomas, et al.
American Heart Journal|September 29, 2014
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Emily C O'Brien, DaJuanicia N Simon, Larry A Allen, et al.
Diabetes Care|July 29, 2025
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary AnalysisPeter Rossing, George Bakris, Vlado Perkovic, et al.
Pageof 64

Showing results (251-260 of 635) with videos related to

Sort By:
Pageof 64
Journal of the American College of Cardiology|December 17, 2016
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II RegistryBenjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
Journal of the American College of Cardiology|February 11, 2003
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patientsPadma Kaul, L Kristin Newby, Yuling Fu, et al.
Circulation|December 14, 2021
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADERAhmed M Shaman, Stephen C Bain, George L Bakris, et al.
Circulation. Cardiovascular Quality and Outcomes|September 20, 2012
Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trialSteen Husted, Stefan James, Richard C Becker, et al.
American Heart Journal|July 5, 2024
Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health studyJacquelyn B Kercheval, Dennis I Narcisse, Maggie Nguyen, et al.
The American Journal of Cardiology|February 22, 2005
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)Manesh R Patel, Kenneth W Mahaffey, Paul W Armstrong, et al.
Stroke|April 29, 2006
Statin use and sex-specific stroke outcomes in patients with vascular diseaseCheryl D Bushnell, Jeffrey Griffin, L Kristin Newby, et al.
Journal of the American College of Cardiology|September 9, 2017
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF RegistryJustin B Echouffo-Tcheugui, Peter Shrader, Laine Thomas, et al.
American Heart Journal|September 29, 2014
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Emily C O'Brien, DaJuanicia N Simon, Larry A Allen, et al.
Diabetes Care|July 29, 2025
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary AnalysisPeter Rossing, George Bakris, Vlado Perkovic, et al.
Pageof 64